The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition (Q36519383)

14 August 2017

1 reference

title

The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition (English)

1 reference

14 August 2017

1 reference

Astrid K Whitbread

1

0 references

Mitchell G Lawrence

object named as

Mitchell G Lawrence

3

0 references

Judith Clements

object named as

Judith A Clements

5

0 references

author name string

Tara L Veveris-Lowe

2

1 reference

PubMed ID

16800731

14 August 2017

David L Nicol

4

1 reference

14 August 2017

1 June 2006

1 reference

14 August 2017

1 reference

14 August 2017

387

1 reference

14 August 2017

6

1 reference

14 August 2017

707-714

1 reference

Epithelial mesenchymal interactions in cancer and development

14 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

The emerging roles of human tissue kallikreins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

TGFbeta Type III and TGFbeta Type II receptors have distinct activities during epithelial-mesenchymal cell transformation in the embryonic heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Src and Ras are involved in separate pathways in epithelial cell scattering

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Amidolytic activity of prostatic acid phosphatase on human semenogelins and semenogelin-derived synthetic substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Dual roles of E-cadherin in prostate cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Intravital imaging of cell movement in tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Preferential production of latent transforming growth factor beta-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Activation of the 92 kDa type IV collagenase by tissue kallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Molecular markers for predicting prostate cancer stage and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Enzymatic profiling of human kallikrein 14 using phage-display substrate technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Antiangiogenic activity of prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Recombinant prostate specific antigen inhibits angiogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

An overview of epithelio-mesenchymal transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Evidence that the prostate-specific antigen (PSA)/Zn2+ axis may play a role in human prostate cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Human kallikrein 13 involvement in extracellular matrix degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

E-cadherin expression and PSA secretion in human prostate epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Purification and characterization of human kallikrein 11, a candidate prostate and ovarian cancer biomarker, from seminal plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2+), a tight-binding inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Metastasis to bone: causes, consequences and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Alternative splicing isoforms of hippostasin (PRSS20/KLK11) in prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

A causal role for E-cadherin in the transition from adenoma to carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Biochemical characterization of human kallikrein 8 and its possible involvement in the degradation of extracellular matrix proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Slug is an essential target of TGFbeta2 signaling in the developing chicken heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Prostate cancer cell adhesion to bone marrow endothelium: the role of prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

JAGGED1 expression is associated with prostate cancer metastasis and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

The tumor-suppressor function of E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Characterization of recombinant and brain neuropsin, a plasticity-related serine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Markers for the development of early prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Quantitative analysis of kallikrein 15 gene expression in prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Testosterone and prostate specific antigen stimulate generation of reactive oxygen species in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by degenerate PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

The fallacy of epithelial mesenchymal transition in neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

The new human tissue kallikrein gene family: structure, function, and association to disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

Human Kallikrein 13: Production and Purification of Recombinant Protein and Monoclonal and Polyclonal Antibodies, and Development of a Sensitive and Specific Immunofluorometric Assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.089

21 January 2018

Identifiers

DOI

10.1515/BC.2006.089

1 reference

14 August 2017

1 reference

PubMed ID

16800731